Two Sigma Securities’s Gossamer Bio GOSS Stock Holding History

Two Sigma Securities’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.56K	Buy	+726	New	+$16.2K	﹤0.01%	1559
2026 Q1	–	Sell	-338	Closed	-$83.9K	–	1846
2025 Q4	$83.9K	Buy	338 +134	+66%	+$30.6K	0.01%	1002
2025 Q3	$43K	Buy	+204	New	+$36K	0.01%	1009
2024 Q1	–	Sell	-396	Closed	-$28.9K	–	3200
2023 Q4	$28.9K	Buy	396 +267	+207%	+$15.8K	﹤0.01%	2670
2023 Q3	$8.6K	Buy	+129	New	+$11.9K	﹤0.01%	2721
2023 Q1	–	Sell	-1,364	Closed	-$237K	–	2895
2022 Q4	$237K	Buy	+1,364	New	+$898K	0.01%	1773

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Two Sigma Securities's GOSS Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Gossamer Bio (GOSS) in Q2 2026: 726 shares worth $9.56K. The stake represents ﹤0.01% of the portfolio and ranks #1559 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in GOSS as recently as Q4 2025.

Two Sigma Securities first reported a position in GOSS in Q4 2022 and has held it in 6 quarters since. The position peaked at $237K in Q4 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Two Sigma Securities held 726 shares of Gossamer Bio worth $9.56K as of Q2 2026.
Gossamer Bio was a new Two Sigma Securities position in Q2 2026.
Gossamer Bio made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1559 holding.
Two Sigma Securities first reported a position in Gossamer Bio in Q4 2022 and has held it in 6 quarters since.
Two Sigma Securities's Gossamer Bio position peaked at $237K in Q4 2022.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.